AUTHORS RESPOND: Osteoporosis for the practicing neurologist
Micol S.Rothman, University of Colorado School of Medicine, Denver, micol.rothman@ucdenver.edu
Sterling G. West and Michael T. McDermott, University of Colorado School of Medicine, Denver
Submitted June 21, 2014
We thank Drs. Shubhakaran and Khichar for their comments and
appreciate the added discussion of practical implications from
the Indian population perspective. We agree that specialists
in all countries can play a vital role in identifying and
treating patients with osteoporosis.1
Disclosures: M.S. Rothman reports no disclosures. S.G. West
serves on a scientific advisory board for Amgen and owns stock
in Novartis. M.T. McDermott reports no disclosures.
References
1. Rothman MS, West SG, McDermott MT. Osteoporosis for the
practicing neurologist. Neurol Clin Pract 2014;4:34-43.
Disclosures: M.S. Rothman reports no disclosures. S.G. West serves on a scientific advisory board for Amgen and owns stock in Novartis. M.T. McDermott reports no disclosures.
References
1. Rothman MS, West SG, McDermott MT. Osteoporosis for the practicing neurologist. Neurol Clin Pract 2014;4:34-43.